New Delhi: The Drugs Controller General of India (DCGI) has given permission to Serum Institute of India, a Pune-based vaccine…
Even if a coronavirus vaccine is developed successfully by early next year, there won’t be enough to administer all global…
Pune: Serum Institute of India’s (SII) phase 2 trial of Oxford's COVID-19 vaccine candidate is set to commence on Tuesday.…
Pune: Serum Institute of India (SII), on Sunday, issued a clarification that the current claims over commercialising COVISHIELD's availability in…
New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has been found to be safe, according to preliminary results of Phase-I…
Mumbai: Serum Institute of India (SII) will make the COVID-19 vaccine available for $3 per dose to low and middle-income…
India’s Serum Institute and Novavax Inc whose COVID-19 vaccine candidate showed promising results in the initial clinical trials have signed…
New Delhi: There is a recommendation to grant permission to the Serum Institute of India (SII) to conduct the second…
Pharmaceutical giant AstraZeneca has promised not to profit from its COVID-19 vaccine, developed in partnership with Oxford University, during the…
Bhubaneswar: Chief Minister Naveen Patnaik on Wednesday spoke to Serum Institute of India CEO Adar Poonawalla over a video call…